(PharmaNewsWire.Com, September 19, 2017 ) Electrophoresis is the motion of dispersed particles relative to a fluid influenced under a uniform electric field applied spatially. Electrophoresis is used as immunoelectrophoresis which can be used to detect specific proteins like immunoglobulins which act as antibodies. These are part of body’s immune system and protect from foreign proteins. Analyzing these antibodies helps design new therapies to treat these threats and provides insight into conditions like allergies and autoimmune disorders.
The primary factors accounted for the growth of market are rising funding for electrophoresis techniques, rising incidences of chronic diseases, cancer and genetic disorders, growing focus on next generation sequencing (NGS). Growing number of industry-academia research collaborations and growing funding for research on genomic and proteomic techniques will also support in growth of the market. On the other hand, electrophoresis techniques are time consuming operations and offer limited sample analysis and presence of alternative technologies to electrophoresis may curb the growth of market.
The North America market for Electrophoresis is segmented based on Product, Application and End Users. Based on Product – Gel Electrophoresis, Capillary Electrophoresis, Reagents, Geldoc and Imaging. Gel electrophoresis is further segmented to vertical and horizontal electrophoresis, Vertical is further segmented based on gel type as Agarose and Polyacrylamide. Based on Application – Diagnostic, Research, Quality Control. Based on End Users – Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers. Based on Geographical analysis the market is separated into regions of United States of America and Canada. USA is leading the market while Canada is at second place. Growing focus of stakeholders on research projects involving proteins, associated biomolecules and genes has helped USA dominate the market. USA is also expected to grow the fastest due to increasing research funding, growing proteomics and genomics techniques and rising adoption of advanced electrophoresis techniques. Reagents holds the major share in the market in terms of products while gel electrophoresis is expected to grow the fastest and academic and research institutes hold major share in terms of end users. Hospitals and diagnostic centers are expected to grow the fastest.
Some of the key players dominating this market include Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies, Merck Millipore, PerkinElmer, QIAGEN N.V., Lonza Group Ltd., Shimadzu Corporation, Harvard Bioscience, Sebia Group and C.B.S. Scientific Company.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
